Item 4 — Purpose of Transaction
Item 4 of the Original Schedule 13D is hereby amended to add the following paragraph at the end thereof: On August 17, 2026, the Issuer and 3i, LP entered into a letter agreement (the "Letter Agreement"), pursuant to which the Issuer issued to 3i, LP 1,500 shares of Series B Preferred Stock at $1,000 per share and (b) Warrants to purchase 1,153,847 shares of Common Stock at an initial exercise price of $0.23708 per share for no additional consideration, for an aggregate purchase price of $1,500,000. The Issuer and 3i, LP are continuing to negotiate in good faith additional tranches of funding but there are no definitive agreements or understandings that are currently in place between the parties.